Specify a stock or a cryptocurrency in the search bar to get a summary
Sernova Corp
SVASernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada. Address: The Stiller Centre, London, ON, Canada, N6G 4X8
Analytics
WallStreet Target Price
3.36 CADP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SVA
Dividend Analytics SVA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SVA
Stock Valuation SVA
Financials SVA
Results | 2019 | Dynamics |